EBV

Stephanie Gras, Queensland Institute of Medical Research

Analyzing Allelic Polymorphism in the T Cell Receptor and its Impact on Immune Responses in an EBV Setting

 

Judy Tellam, Queensland Institute of Medical Research

Pro5® MHC Class I Pentamer Combined with Intracellular Cytokine Staining Shows How Protein Translation Affects the Molecular Dynamics of Antigen Presentation

Christopher Fox, University of Birmingham
Researchers Use Pro5® MHC Pentamers to Identify an Exciting New Target for EBV Treatment
Michael Uhlin, Karolinska Institute
Pro5® Pentamers Central in Life-saving Procedure for PTLD Treatment
Michael Uhlin, Karolinska Institute
Invited Editorial: The Best Strategy for Adoptive T Cell Transfer		 flow plot

Suzanne Elliot, Queensland Institute of Medical Research
Pro5® MHC Class I Pentamers Used to Evaluate Vaccine Safety

John J. Miles, Cardiff University School of Medicine
Invited Editorial: Tracking the TCR Repertoire Evolution During Primary Viral Infection in Humans

More EBV publications citing ProImmune